✨ 5 results found - Searched 21220 records in 4ms.
Disertasi
Peran MicroRNA-224 dan MicroRNA-544a, serta Sel Punca Kanker terhadap Respons Kemoterapi Berbasis Platinum Kanker Paru Jenis Karsinoma Bukan Sel Kecil (KPKBSK) Stage Lanjut
2024 | BY Lisnawati - Asmarinah. - Elisna Syahruddin - Erna Kristiani- The Role of MicroRNA-224 dan MicroRNA-544a and Its Stemness to the Resistance of Platinum-based Chemotherapy in Patient with Advanced Stage Non-Small Cell Lung Cancer.
- Nomor Panggil D24039fk
Tesis
Hubungan rasio trombosit limfosit dan rasio neutrofil limfosit darah dengan respons klinis pada pasien kanker paru karsinoma bukan sel kecil stage lanjut yang mendapat kemoterapi
2022 | BY Eliasta Simpar Sitepu - Dianiati Kusumo Sutoyo - Andika Chandra Putra - Jamal Zaini- Relationship between serum platelets to lymphocytes ratio and serum neutrophils to lymphocytes ratio with clinical response in advanced stage non-small cell lung cancer patients receiving chemotherapy.
- Nomor Panggil T22442fk
Tesis
Perbandingan Efikasi Dan Toksisitas Hematologi Kemoterapi Lini I Kanker Paru Karsinoma Bukan Sel Kecil (KPKBSK) Jenis Karsinoma Sel Skuamosa (KSS) Dengan Adenokarsinoma EGFR wild typeDi RSUP Persahabatan
2018 | BY Enita Mayasari - Elisna Syahruddin - Andika Chandra Putra- The Efficacy and Hematological Toxicity of First-line Chemotherapy of Non-small Cell Lung Cancer (NSCLC) Patients Treated at Persahabatan Hospital Jakarta, Indonesia .
- Nomor Panggil T18483fk
Tesis
Analisis Potensi Interaksi Obat Pada Tatalaksana Kanker Paru Karsinoma Bukan Sel Kecil (KPKBSK) Stage Lanjut di RS Kanker Dharmais Tahun 2023
2024 | BY Anggi Gayatri - Purwantyastuti Ascobat - Noorwati Soetandyo - Yolanda Safitri- Analysis of Potential Drug Interactions in the Management of Non-Small Cell Carcinoma Lung Cancer (NSCLC) Advanced Stage at Dharmais Cancer Hospital in 2023.
- Nomor Panggil T24404fk
Tesis
Masa tahan Hidup Pasien Kanker Paru Jenis Karsinoma Jenis Sel Kecil yang Mendapat Monoterapi Dosetaksel sebagai Kemoterapi Lini Kedua dan Faktor Faktor yang Mempengaruhi
2014 | BY Fadlun Bukayer - Anwar Jusuf - Elisna Syahruddin- SURVIVAL RATE OF DOCETAXEL AS SECONDLINE CHEMOTHERAPY FOR NSCLC PATIENTS IN PERSAHABATAN HOSPITAL JAKARTA.
- Nomor Panggil T14334fk